Corpus 1,272 assessed · 1,173 scored · 643 reproduced ≥75 · 168 flagged ·∅ 74.1/100

Publications 4 Datasets 392.5k Experiments 4.7k

Explore

Filters: Medicine ✕ whole-exome sequencing (wes) ✕ clear all

4 matching publication(s)

Publication	Journal	Year	Score	Verdict
Genomics Define Malignant Transformation in Myeloma Precursor Conditions. PMID 41061199	J Clin Oncol	2025	78	L1 78/100
Tumor-specific but immunosuppressive CD39+CD8+ T cells exhibit double-faceted roles in clear cell renal cell carci PMID 40961944	Cell Rep Med	2025	88	L1 88/100
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104). PMID 38897205	Cell Rep Med	2024	72	L1 72/100
Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer. ⚑ PMID 35311085	Front Oncol	2022	30	L1 30/100 ⚑

Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

PMID 41061199 · J Clin Oncol · 2025

L1 78/100

Tumor-specific but immunosuppressive CD39+CD8+ T cells exhibit double-faceted roles in clear cell renal cell carci

PMID 40961944 · Cell Rep Med · 2025

L1 88/100

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).

PMID 38897205 · Cell Rep Med · 2024

L1 72/100

Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer.⚑

PMID 35311085 · Front Oncol · 2022

L1 30/100 ⚑